TATSIS OURANIA (SVP, CRO) received a stock award from VERTEX PHARMACEUTICALS INC / MA
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/23/2026ACC: 0000875320-26-000253
Officer· SVP, CRO
Since Oct 2019
+8.25K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
8.25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+8.25K
Price / share
—
Trade value
—
% of position
18.2%
7/21/2026
45.32K→53.57K
Total
Net shares
+8.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/21/2026 | A · Award | +8.25K | — | — | 18.2% | 45.32K | 53.57K |
| Total | +8.25K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported